Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model

Soylu-Kucharz, Rana LU ; Khoshnan, Ali and Petersén, Åsa LU (2022) In iScience 25(2). p.1-16
Abstract

Huntington disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin (HTT) gene. Metabolic changes are associated with HD progression, but underlying mechanisms are not fully known. As the IKKβ/NF-κB pathway is an essential regulator of metabolism, we investigated the involvement of IKKβ, the upstream activator of NF-κB in hypothalamus-specific HD metabolic changes. We expressed amyloidogenic N-terminal fragments of mutant HTT (mHTT) in the hypothalamus of mice with brain-specific ablation of IKKβ (Nestin/IKKβlox/lox) and control mice (IKKβlox/lox). We assessed effects on body weight, metabolic hormones, and hypothalamic neuropathology. Hypothalamic expression of mHTT led to an obese phenotype only... (More)

Huntington disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin (HTT) gene. Metabolic changes are associated with HD progression, but underlying mechanisms are not fully known. As the IKKβ/NF-κB pathway is an essential regulator of metabolism, we investigated the involvement of IKKβ, the upstream activator of NF-κB in hypothalamus-specific HD metabolic changes. We expressed amyloidogenic N-terminal fragments of mutant HTT (mHTT) in the hypothalamus of mice with brain-specific ablation of IKKβ (Nestin/IKKβlox/lox) and control mice (IKKβlox/lox). We assessed effects on body weight, metabolic hormones, and hypothalamic neuropathology. Hypothalamic expression of mHTT led to an obese phenotype only in female mice. CNS-specific inactivation of IKKβ prohibited weight gain in females, which was independent of neuroprotection and microglial activation. Our study suggests that mHTT in the hypothalamus causes metabolic imbalance in a sex-specific fashion, and central inhibition of the IKKβ pathway attenuates the obese phenotype.

(Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
iScience
volume
25
issue
2
article number
103771
pages
1 - 16
publisher
Elsevier
external identifiers
  • pmid:35146388
  • scopus:85123690679
ISSN
2589-0042
DOI
10.1016/j.isci.2022.103771
language
English
LU publication?
yes
additional info
© 2022 The Author(s).
id
82193556-95d6-4520-bd92-daa3a098a908
date added to LUP
2022-02-15 09:31:30
date last changed
2024-06-27 12:07:51
@article{82193556-95d6-4520-bd92-daa3a098a908,
  abstract     = {{<p>Huntington disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin (HTT) gene. Metabolic changes are associated with HD progression, but underlying mechanisms are not fully known. As the IKKβ/NF-κB pathway is an essential regulator of metabolism, we investigated the involvement of IKKβ, the upstream activator of NF-κB in hypothalamus-specific HD metabolic changes. We expressed amyloidogenic N-terminal fragments of mutant HTT (mHTT) in the hypothalamus of mice with brain-specific ablation of IKKβ (Nestin/IKKβlox/lox) and control mice (IKKβlox/lox). We assessed effects on body weight, metabolic hormones, and hypothalamic neuropathology. Hypothalamic expression of mHTT led to an obese phenotype only in female mice. CNS-specific inactivation of IKKβ prohibited weight gain in females, which was independent of neuroprotection and microglial activation. Our study suggests that mHTT in the hypothalamus causes metabolic imbalance in a sex-specific fashion, and central inhibition of the IKKβ pathway attenuates the obese phenotype.</p>}},
  author       = {{Soylu-Kucharz, Rana and Khoshnan, Ali and Petersén, Åsa}},
  issn         = {{2589-0042}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{1--16}},
  publisher    = {{Elsevier}},
  series       = {{iScience}},
  title        = {{IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model}},
  url          = {{http://dx.doi.org/10.1016/j.isci.2022.103771}},
  doi          = {{10.1016/j.isci.2022.103771}},
  volume       = {{25}},
  year         = {{2022}},
}